Previous research has demonstrated that glucocorticoid treatment during productive infection can reduce the expression of both viral lytic genes and host inflammatory genes, and that the activated GR can bind to one of the origins of replication in the HSV-1 genome, potentially limiting viral gene expression, genome replication, and severity of acute disease [55,56]. This evidence concerns the gene NR3C1 and infection.